[go: up one dir, main page]

UA64800C2 - Antiseptic for eyes - Google Patents

Antiseptic for eyes Download PDF

Info

Publication number
UA64800C2
UA64800C2 UA2001010041A UA200110041A UA64800C2 UA 64800 C2 UA64800 C2 UA 64800C2 UA 2001010041 A UA2001010041 A UA 2001010041A UA 200110041 A UA200110041 A UA 200110041A UA 64800 C2 UA64800 C2 UA 64800C2
Authority
UA
Ukraine
Prior art keywords
eyes
antiseptic
same
group
animals
Prior art date
Application number
UA2001010041A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрій Семенович Кривошеін
Адоліна Петрівна Рудько
Адолина Петровна Рудько
Original Assignee
Юрій Семенович Кривошеін
Адоліна Петрівна Рудько
Адолина Петровна Рудько
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20233909&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA64800(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Юрій Семенович Кривошеін, Адоліна Петрівна Рудько, Адолина Петровна Рудько filed Critical Юрій Семенович Кривошеін
Publication of UA64800C2 publication Critical patent/UA64800C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the medicine, in particular to ophthalmology. The antiseptic for eyes is disclosed. The composition comprises Miramystin, isotonic saline solution or isotonic saline solution of increased viscosity.

Description

заявлених за формою винаходу. Заявлений очний антисептик нешкідливий для організму і є високоефективним засобом для лікування гнійно-запальних уражень очей.claimed according to the form of the invention. The declared eye antiseptic is harmless to the body and is a highly effective means for the treatment of purulent-inflammatory lesions of the eyes.

Таблиця 1Table 1

Склади очного антисептику за експериментальними групамиFormulations of eye antiseptic according to experimental groups

КомпонентиComponents

Мірамістин 0,005Miramistin 0.005

Розріджувач до 100 до 100 до 100 до 100Thinner to 100 to 100 to 100 to 100

Склад розріджувачаThe composition of the thinner

ІРХН 996 2 щ- | (9950 2 7 щ-| 100 | 00IRKHN 996 2 sh- | (9950 2 7 sh-| 100 | 00

Гідроксиетилцелюлоза | 04 | - | - |! -Hydroxyethyl cellulose | 04 | - | - |! -

Метилцелюлоза ниж шишки Пи ПОMethylcellulose is lower than Pi PO cones

Таблиця 2.Table 2.

Результати лікування гнійно-запальних уражень роговиці очей у кролів ЗС і препаратом порівнянняThe results of the treatment of purulent-inflammatory lesions of the cornea in rabbits with ZS and a comparison drug

Ознаки терапевтичного | Номер групи ефе тарин | 2 1. 3 Її 4 1 5 | 6 ЇЇ 7 | в ЇЇ 10 | 12114 | 16 | 18 | »Signs of therapeutic | Number of the group Efe tarin | 2 1. 3 Her 4 1 5 | 6 HER 7 | in HER 10 | 12114 | 16 | 18 | »

Відсутність гнійного Іа 48(10) 92(10) 100010) | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | тсаме | т.саме | т.саме | т.саме відокремлюваним очей 16 36(8) 84(8) 99(8) 100(8) | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме ) т.саме | т.саме ) т.саме 18 8(8) 15(8) 56(8) 86(8) 96(8) | 100(8) | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме 2 1909) 14(9) 58(9) 90(9) 10009) | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме 3 (6) (6) (6) дб) Ф(6у 1406) | 5205) | 68(6) | 6806) | 8706) | 8706) | 8806) | 109(6)Absence of purulent Ia 48(10) 92(10) 100010) | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | tsame | i.e. | i.e. | i.e. separable eyes 16 36(8) 84(8) 99(8) 100(8) | i.e. | i.e. | i.e. | i.e. | i.e. | t.same ) t.same | t.same ) t.same 18 8(8) 15(8) 56(8) 86(8) 96(8) | 100(8) | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. 2 1909) 14(9) 58(9) 90(9) 10009) | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. 3 (6) (6) (6) db) F(6y 1406) | 5205) | 68(6) | 6806) | 8706) | 8706) | 8806) | 109(6)

Відсутність 5.айгей5 іа (10) 92410) 100010) | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме відокремлюючого очей 16 Ф(8) 52(8) 86080 | 10008) | т.саме ) т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.семе ів 0(8) 42(8) 648) 92(8) 100(8) | т.саме | т.саме | т.саме ) т.саме | тсаме | т.саме | т.саме | т.саме 2 Ф(9) 46(9) сво 90(9) 10009) | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.самеAbsence 5.aygey5 ia (10) 92410) 100010) | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | that is, of the separating eye 16 F(8) 52(8) 86080 | 10008) | t.same ) t.same | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | t.seme iv 0(8) 42(8) 648) 92(8) 100(8) | i.e. | i.e. | t.same ) t.same | tsame | i.e. | i.e. | i.e. 2 F(9) 46(9) svo 90(9) 10009) | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e

Е об) о(6) (6) об о(63 | 1466) | 52063 | 6806) | 6806) | 8706) | 8706) | 8706) | 10006)E ob) o(6) (6) o o(63 | 1466) | 52063 | 6806) | 6806) | 8706) | 8706) | 8706) | 10006)

Розсмоктування гвійного іа 9019) 4819) 74410) | 100010) | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | тсаме | т.саме інфільтрату 16 (8) 38(8) б66(8) 92(8) 100(8) | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме | т.саме ів о(8) 10(8) 38(8) 428) 5808) ! 66(8) 86(8) 94(8) | 100(8) | т.саме | т.саме | т.саме | т.саме 2 09) о(9у 1209) 46(9) 5809) | 6809) | 9009) | 100093 | т.саме | т.саме | т.саме | тсаме | т.саме 3 (6) Ф(6 о(б) що (б) дб) 18(6) | 18065 | 3605) | 36065 | 3605) | 66(6) | 68(6)Resorption of the spinal cord 9019) 4819) 74410) | 100010) | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | tsame | i.e. infiltrate 16 (8) 38(8) b66(8) 92(8) 100(8) | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. | i.e. iv o(8) 10(8) 38(8) 428) 5808) ! 66(8) 86(8) 94(8) | 100(8) | i.e. | i.e. | i.e. | i.e. 2 09) o(9u 1209) 46(9) 5809) | 6809) | 9009) | 100093 | i.e. | i.e. | i.e. | tsame | i.e. 3 (6) F(6 o(b) what (b) db) 18(6) | 18065 | 3605) | 36065 | 3605) | 66(6) | 68(6)

Епітелізація 1а 22(10) 3210) 32410) | 54(10) | 80010) | 82010) | 86(10) | 1000103 | т.саме | т.саме | т.саме | т.саме ; т.саме 16 1608) 26(8) 3008) | 44083 | 5608) | 6408) | 76(8У | 8803) | 100(8) | т.саме | т.саме | т.саме | т.самеEpithelialization 1a 22(10) 3210) 32410) | 54(10) | 80010) | 82010) | 86(10) | 1000103 | i.e. | i.e. | i.e. | i.e. the same i.e. 16 1608) 26(8) 3008) | 44083 | 5608) | 6408) | 76(8U | 8803) | 100(8) | i.e. | i.e. | i.e. | i.e

Ів В) 483 (8) 10083 | 1208у | 22083 | 2208) | 3483 | з8(8) | 68(83 | 9208 | 10008) | т.саме 2 (9) (9) 0(9) 12093 | 12093 | 2509) | 2509) | 360) | з6(9) | 79093 | 10009) | т.саме | т.саме 3 (6 (6 006) | о (6 (6 (6 06) | 18066) | 1806) | зе) | 3605) | 526Iv V) 483 (8) 10083 | 1208u | 22083 | 2208) | 3483 | z8(8) | 68(83 | 9208 | 10008) | i.e. 2 (9) (9) 0(9) 12093 | 12093 | 2509) | 2509) | 360) | z6(9) | 79093 | 10009) | i.e. | i.e. 3 (6 (6 006) | o (6 (6 (6 06) | 18066) | 1806) | ze) | 3605) | 526

Примітка: "7 -1а група тварин, яка отримавала склад іа -16 група тварин, яка отримавала склад 16 -Ів група тварин, яка отримавала склад 18 -2 група тварин, яка отримавала софрадекс -3 контрольна група тварин, яка отримавала ІРХН жж - у дужках кількість очей, які були оглянутіNote: "7 - 1a group of animals that received composition ia - 16 group of animals that received composition 16 - IV group of animals that received composition 18 - 2 group of animals that received sofradex - 3 control group of animals that received IRCHN zhzh - in parentheses is the number of eyes that were examined

UA2001010041A 2000-04-27 2001-03-20 Antiseptic for eyes UA64800C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000110541A RU2164135C1 (en) 2000-04-27 2000-04-27 Ophthalmic antiseptic agent

Publications (1)

Publication Number Publication Date
UA64800C2 true UA64800C2 (en) 2004-03-15

Family

ID=20233909

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001010041A UA64800C2 (en) 2000-04-27 2001-03-20 Antiseptic for eyes

Country Status (3)

Country Link
EA (1) EA003408B1 (en)
RU (1) RU2164135C1 (en)
UA (1) UA64800C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011101113A1 (en) 2010-02-19 2011-08-25 Megainpharm Gmbh Pharmaceutical comprising myramistin

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008039254A1 (en) 2008-08-20 2010-02-25 Megainpharm Gmbh Medicament, useful e.g. for treating infectious- and purulent inflammatory diseases of e.g. eyes, comprises benzyl-dimethyl-(3-(myristoylamino)-propyl)-ammonium chloride, dimethyl-(3-(myristoylamino)-propyl)-amine oxide and solvent
WO2014175757A1 (en) 2013-04-22 2014-10-30 Общество с ограниченной ответственностью "Нанобиотех" Antiseptic veterinary formulation and methods for use thereof
RU2755298C1 (en) * 2020-11-09 2021-09-15 Юлия Александровна Корнева Contact lens care solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1832496A1 (en) * 1978-08-02 1996-04-27 Н.М. Овчинников Antiseptic agent "miramistin" for venereal disease prophylaxis
RU2139095C1 (en) * 1998-04-23 1999-10-10 Научно-производственное предприятие ООО "ЛИНКО" Enzymatic composition for cleaning contact lenses
RU2139094C1 (en) * 1998-04-23 1999-10-10 Научно-производственное предприятие ООО "ЛИНКО" Composition for treating contact lenses

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011101113A1 (en) 2010-02-19 2011-08-25 Megainpharm Gmbh Pharmaceutical comprising myramistin
WO2011100994A1 (en) * 2010-02-19 2011-08-25 Megainpharm Gmbh Pharmaceutical comprising myramistin
EA022283B1 (en) * 2010-02-19 2015-12-30 Мегаинфарм Гмбх Pharmaceutical comprising benzyldimethyl[3-(myristoylamino)propyl]ammonium chloride
MD4411C1 (en) * 2010-02-19 2016-11-30 Megainpharm Gmbh Pharmaceutical including benzyldimethyl(3-[myristoylamino]propyl)-ammonium chloride and its use for the treatment and prevention of infectious and pyoinflammatory diseases of different etiology and localization

Also Published As

Publication number Publication date
EA200100197A1 (en) 2001-12-24
RU2164135C1 (en) 2001-03-20
EA003408B1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
CA2595132C (en) Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) Agents for controlling biological fluids and methods of use thereof
JP2611159B2 (en) Hyaluronic acid pharmacologically active fraction, method for producing the same and pharmaceutical composition
US20070059350A1 (en) Agents for controlling biological fluids and methods of use thereof
CA2341410C (en) Hydrogel compositions for the controlled release administration of growth factors
MXPA04000764A (en) Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide.
CN103182070B (en) External composition, and preparation and application thereof
Ballard et al. Developments in wound care for difficult to manage wounds
KR20210075051A (en) Composition for for treating wound or scar comprising hydrogel patches
CN112272578A (en) Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced toxicity
US7807656B2 (en) Pharmaceutical applications of hyaluronic acid preparations
Milburn et al. Treatment of scleroderma skin ulcers with a hydrocolloid membrane
UA64800C2 (en) Antiseptic for eyes
US20180200340A1 (en) Wound Treatment
Gupta et al. Calcium alginate in the management of acute surgical wounds and abscesses
JP5796728B1 (en) A biofilm for the purpose of promoting wound healing and covering (coaching) and protecting living organs.
US11576926B2 (en) Composition for use in the prevention and/or treatment of epistaxis
EP2590666B1 (en) Topical application of erythropoietin for use in the treatment of injuries of the cornea
MXPA01003507A (en) Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide.
Dziewulski et al. Acute management of facial burns
Ghosh et al. Preclinical and clinical study of polysaccharide-based hydrogels
RU2319487C1 (en) Composition for antibacterial dressing material and method for treatment of suppurative wounds
Santhan A Comparative Study between Efficacy Of Topical Sucralfate And 5% Povidone Iodine In Chronic Lower Limb Ulcers
RU2192266C2 (en) Method for preparing skin cover defect to autodermoplasty operation
MILLER et al. The Use of the Antibacterial Drugs and Streptokinase: Administered Intramuscularly in Enucleation of the Eye.